EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort

Álvaro Carbayo iD, Janina Turon-Sans, Daniel Alcolea, Elena Cortés-Vicente, Manuel Cabezas-Torres, Esther Alvarez-Sanchez, Laia Muñoz, Sara Rubio-Guerra, Jesús García-Castro, Judit Selma-González, Sara Bernal, Lidia Gonzalez-Quereda und 15 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Álvaro Carbayo und 26 weiteren Autor:innen. Beteiligte Einrichtung: Motor Neuron Disease Clinic, Neuromuscular Diseases Unit, Department of Neurology, IR Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spai…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Frontotemporal Lobar Degeneration. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundació Víctor Grífols i Lucas, Instituto de Salud Carlos III, Fundació la Marató de TV3.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) constitute a clinico‐genetic‐neuropathological continuum with marked heterogeneity. Reliable in vivo biomarkers of the disease are lacking. Large, multimodal cohorts are needed to advance biomarker discovery and precision medicine. METHODS We describe the structure and results derived from the Sant Pau Initiative on Neurodegeneration (SPIN)‐ALS‐FTLD subcohort, a longitudinal, multimodal platform that integrates clinical, cognitive, genetic, biofluid, neuroimaging, and neuropathological data within a unified framework embedded in routine care. RESULTS The cohort includes over 1000 participants, 800 blood, 400 CSF, and 800 DNA samples, neuroimaging in over 250 cases, and 66 neuropathological studies. Harmonized longitudinal data and biospecimen collection have enabled substantial clinical, molecular, and translational research output. DISCUSSION SPIN‐ALS‐FTLD extends the original SPIN framework to the ALS‐FTLD continuum, enabling deep phenotyping and multimodal biomarker discovery. This scalable model supports patient stratification, longitudinal monitoring, and the development of precision medicine approaches in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisFrontotemporal Lobar DegenerationHumansBiomarkersCohort StudiesNeuroimagingMaleFemaleLongitudinal StudiesPrecision MedicineAgedMiddle Aged

Stichwörter der Autor:innen

ALS–FTLD spectrumamyotrophic lateral sclerosisbiofluidsbiomarkerscohort studyfrontotemporal lobar degenerationgeneticslongitudinal registrymultimodal cohortneurodegenerationneuroimagingneuropathologyprecision medicinetranslational research

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Motor Neuron Disease Clinic, Neuromuscular Diseases Unit, Department of Neurology, IR Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, CIBERNED, Madrid, Spain.
  • Genetics Department, Joint Research Unit on Genomic Medicine, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau, Universitat Autònoma de Barcelona-IR SANT PAU, Barcelona, Spain.
  • Genome Instability and DNA Repair Group, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain.

ORCID-Profile: Álvaro Carbayo, Oriol Dols-Icardo, Ignacio Illán-Gala

Förderung

  • Fundació Víctor Grífols i Lucas
  • Instituto de Salud Carlos III
  • Fundació la Marató de TV3
  • NIA NIH HHS
  • Fundació Bancaria "La Caixa"
  • Alzheimer's Association
  • Fondo Europeo de Desarrollo Regional (FEDER)
  • Fundación HNA

Zitieren

APA

Carbayo, Á., Turon-Sans, J., Alcolea, D., Cortés-Vicente, E., Cabezas-Torres, M., Alvarez-Sanchez, E., Muñoz, L., Rubio-Guerra, S., García-Castro, J., Selma-González, J., Bernal, S., Gonzalez-Quereda, L., Bejanin, A., Aranha, M. R., Santos-Santos, M., Belbin, O., Vesperinas-Castro, A., Collet-Vidiella, R., Caballero-Ávila, M., …, & Rojas-Garcia, R. (2026). Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71777

Vancouver

Carbayo Á, Turon-Sans J, Alcolea D, Cortés-Vicente E, Cabezas-Torres M, Alvarez-Sanchez E, et al. Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71777

BibTeX
@article{Carbayo2026,
  author = {Carbayo, Álvaro and Turon-Sans, Janina and Alcolea, Daniel and Cortés-Vicente, Elena and Cabezas-Torres, Manuel and Alvarez-Sanchez, Esther and Muñoz, Laia and Rubio-Guerra, Sara and García-Castro, Jesús and Selma-González, Judit and Bernal, Sara and Gonzalez-Quereda, Lidia and Bejanin, Alexandre and Aranha, Mateus Rozalem and Santos-Santos, Miguel and Belbin, Olivia and Vesperinas-Castro, Ana and Collet-Vidiella, Roger and Caballero-Ávila, Marta and Llansó, Laura and Querol, Luis and Lleó, Alberto and Fortea, Juan and Gelpí, Ellen and Dols-Icardo, Oriol and Illán-Gala, Ignacio and Rojas-Garcia, Ricard},
  title = {Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71777}
}
Kostenlos starten →